Upton and DeGette Urge Administration to Rethink NIH Budget Cuts
U.S. Rep. Fred Upton, R-Michigan, and U.S. Rep. Diana DeGette, D-Colorado, sent a letter to Office of Management and Budget Director Mick Mulvaney to express opposition to any cuts to the National Institutes of Health (NIH) Fiscal Year 2017 or 2018 budget.
“NIH research saves millions of lives every year making the basic discoveries that allow businesses to develop new treatments, medications, and cures for patients,” write Upton and DeGette. “In FY16, investments in biomedical research directly supported over 379,000 jobs and indirectly supported another 1.62 million Americans working in the bioscience industry, powering $65 billion in economic growth nationwide. Those investments will be crucial to controlling long-term entitlement costs. Today, 1 out of 3 Medicare dollars is spent on diabetes-related care, and 1 out of 5 Medicare dollars is spent on Alzheimer’s related care. Without new research to find cures, these diseases will bankrupt our nation.
“This is not a partisan issue. Disease isn’t Democratic or Republican. Congress voted to reinvest in NIH research because we recognize its remarkable return on investment for the American people, and so we oppose any cuts to the NIH budget in FY17 or FY18. NIH research saves lives, creates jobs, controls long-term entitlement costs, protects our national security, and advances our global leadership, all while bringing renewed hope to patients and families across the country.”
To read the full letter, please click here.
In 2016, Upton and DeGette lead the successful 21st Century Cures effort that invested $4.8 billion to accelerate life-saving research at the NIH. The 21st Century Cures Act passed the U.S. House of Representatives by a 392-26 vote and in the Senate by a 94-5 margin. It was signed into law on December 13, 2016, by President Obama.